Abstract
Nephrotoxicity is an undesirable reaction of contrast media used in X-ray or magnetic resonance diagnostics. In addition to a direct toxic effect on renal tubules, the hemodynamic factor is considered to be the main cause of kidney damage and malfunction. The factors that increase the probability of a nephrotoxic effect of contrast media include oldage, diabetes, arterial hypertension, circulatory system insufficiency, neoplastic diseases, and prior kidney damage. Decreased serum zinc is observed in all those conditions. In this article, the influence of contrast media on zinc homeostasis and the possibility of a nephrotoxic reaction caused by these agents is discussed.
Similar content being viewed by others
References
B. Barret, Contrast nephrotoxicity,J. Am. Soc. Nephrol. 5, 125–129 (1994).
A. Berns, Nephrotoxicity of contrast media,Kidney Int. 36, 730–736 (1989).
S. Heyman, S. Rosen, and M. Brezis, Radiocontrast nephropathy: a paradigm for the synergism between toxic and hypoxic insults in the kidney,Exp. Nephrol. 2, 152–158 (1994).
G. Porter, Radiocontrast-induced nephropathy,Nephrol. Dial. Transplant. 9(Suppl.4), 146–150 (1994).
M. Rudnick, J. Berns, R. Cohen, and S. Goldfarb, Nephrotoxic risks of renal angiography: contrast media-associated nephrotoxicity and atheroembolism–a critical review,Am. J. Kidney Dis. 24, 713–718 (1994).
H. S. Thomsen and S. K. Morcos, Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines,Br. J. Radiol. 76, 513–518 (2003).
C. Brigouri, A. Colombo, F. Airoldi, et al., Gadolinium-based contrast agents and nephrotoxicity in patients undergoing coronary artery procedures,Catheter. Cardiovasc. Intervent 67, 175–180 (2006).
T. Larson, K. Hudson, and J. Mertz, J. C. Romero, and F. G. Knox, Renal vasoconstriction respons to contrast media. The role of sodium balance and the renin-angiotensin system,J. Lab. Ciln. Med. 101, 385–391 (1983).
G. Vivoli, M. Bergomi, S. Rovesti, M. Pinotti, and E. Caselgrandi, Zinc, copper and Zn- or copper-dependent enzymes in human hypertension,Biol. Trace Element Res. 49, 97–106 (1995).
W. B. Kinlaw, A. S. Levine, J. E. Morley, S. E. Silvis, and J. C. McClain, Abnormal zinc metabolism in type II diabetes mellitus,Am. J. Med. 75, 273–280 (1983).
S. Tubek, The Zn content in lymphocytes and the activity of zinc ions efflux from lymphocytes in primary arterial hypertension,Biol. Trace Element Res. 107, 89–99 (2005).
B. L. Vallee and K. H. Falchuk, The biochemical basis of zinc physiology,Physiol. Rev. 73, 79–91 (1993).
E. S. Harpur, D. Worak, P. A. Hals, E. Holtz, K. Furuhama, and H. Nomma, Preclinical safety assesment and pharmacokinetics of gadodiamide injection, a new magnetic resonance imaging contrast media,Invest. Radiol. 28(Suppl. 1), S28-S43 (1993).
Editorial: Importance of zinc for hormone binding and signal transduction: limiting mechanisms in Zn deficiency?Nutr. Rev. 49, 369–370 (1991).
M. Chvapil, Effect of zinc on cell and biomembranes,Med. Clin. North Am. 60, 799–808 (1976).
J. Cortijo, J. V. Esplugues, and B. Sarria, Zinc as a calcium antagonist; a pharmacological approach in strips of rat aorta,IRCS Med. Sci. Cancer 13, 292–293 (1985).
N. Harrison and S. Gibbons, Zn2+: an endogenous modulator of ligand- and voltagegated ion channels,Nueropharmacology 33, 935–960 (1994).
L. Ruilope, V. Lahera, and J. Rodicio, Evaluation of the renal effects of calcium antagonists,J. Cardiovasc. Pharmacol. 23(Suppl. 5), S49-S54 (1994).
K. Hayakawa, Y. Ohuno, and Y. Shimizu, Effect of iodinated contrast media on ionic calcium,Acta Radiol. 35, 83–86 (1994).
N. R. Puttagunta, W. A. Gibby, and G. T. Smith, Human in vivo comparative study of zinc and copper transmetallation after administration of magnetic resonance imaging contrast agents,Invest. Radiol. 31, 739–742 (1996).
M. Calero, A. Sampalo, J. E. Millan, J. Freire, A. Senra, and E. Zamora, Changes in the activity of plasma renin and aldosterone induced by a pattern of increasing administration of Zn sulphate in normotensive individuals,Med. Clin. (Barc.) 92, 729–732 (1989) (abstract).
W. J. Bettger and B. L. O’Dell, A critical physiological role of zinc in the structure and function of biomembranes,Life Sci. 28, 1425–1438 (1981).
M. D. Noseworthy and T. M. Bray, Zinc deficiency exacerbates loss in blood-brain barrier integrity induced by hyperoxia measerd by dynamic MRI,Proc. Soc. Exp. Biol. Med. 223, 175–182 (2000).
M. Capasso, J. M. Jeng, M. Malavolta, E. Mocchegiani, and S. L. Sensi, Zinc dyshomeostasis: a key modulator neuronal injury,J. Altzheimer’s Dis. 8, 93–108 (2005).
S. Tubek, Correlations between serum zinc concentrations and oxygen balance parameters in patients with primary arterial hypertension,Biol. Trace Element Res. in press.
H. Pedersen, E. Jacobsen, H. Reisum, and N. Klow, Cardiac effects of coronary arteriography with electrolyte additon to iohexol: A study in dogs with and without heart failure,Acta Radiol. 35, 77–81 (1994).
S. Tubek and I. Tubek, The effect of 75% uropolinum administration on zinc serum concentration in patients undergoing intravenous urography,Problemy Terapii Monitorowanej 8, 82–85 (1997) (in Polish).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tubek, S., Tubek, I. Significance of zinc in nephrotoxicity of contrast media used in imaging diagnostics of the cardiovascular system. Biol Trace Elem Res 117, 1–5 (2007). https://doi.org/10.1007/BF02698078
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02698078